DiscoverIDBR Infectious Disease Board ReviewGaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD
Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

Update: 2024-07-22
Share

Description

A 36-year-old obese white man (BMI 34) recently diagnosed with HIV (CD4 560, HIV RNA 52,000) is recommended to start antiretroviral therapy but is concerned about weight gain.


Which is true of antiretroviral-induced weight gain?


A. Raltegravir is associated with more weight gain than dolutegravir


B. Elvitegravir is associated with more weight gain than bictegravir


C. Tenofovir AF is associated with more weight gain than tenofovir DF


D. White men have the highest rates of weight gain on ART




⁠www.idbrcourse.org/⁠  © 2024 IDBR LLC | All Rights Reserved

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

Gaining weight on antiretrovirals - Trip Gulick, MD/ Michael Saag, MD

John Bennett, MD / Henry Masur, MD